相似文献/References:
[1]徐卫东,张玉红.人工流产后即时放置TCu220与曼月乐的疗效分析[J].中国计划生育和妇产科,2010,(02):0.
[2]尚思慧,林琬君.左炔诺孕酮宫内缓释系统的非避孕应用[J].中国计划生育和妇产科,2011,(06):0.
SHANG Si-hui,LIN Wan-jun.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(02):0.
[3]葛庆玲,李美,李延丽,等.宫腔镜联合B超在子宫内膜息肉诊断中的应用分析[J].中国计划生育和妇产科,2015,(01):0.
GE Qing-ling,LI Mei,LI Yan-li,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(02):0.
[4]宋芷霜,郭宝芝,刘爱珍,等.左炔诺孕酮宫内缓释系统预防子宫内膜息肉复发的临床观察[J].中国计划生育和妇产科,2015,(02):0.
SONG Zhi-shuang,GUO Bao-zhi,LIU Ai-zhen,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(02):0.
[5]陆洋,李慧,李晓红,等.子宫内膜息肉患者Th1/Th2细胞因子的血清学研究[J].中国计划生育和妇产科,2016,(01):0.
LU Yang,LI Hui,LI Xiao-hong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(02):0.
[6]孙馥箐,段华.子宫内膜异位症不孕患者子宫内膜病变特征分析[J].中国计划生育和妇产科,2016,(07):0.
SUN Fu-qing,DUAN Hua,Minimally Invasive Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(02):0.
[7]孟萍萍,汤小晗,卢美松*.子宫内膜息肉复发机制的研究进展[J].中国计划生育和妇产科,2017,(5):33.
[8]庄文月,左欣,朱红娣*.宫腔镜引导选择性内膜切除子宫内膜息肉的综合疗效及复发率观察[J].中国计划生育和妇产科,2017,(7):44.
ZHUANG Wen-yue,ZUO Xin,ZHU Hong-di*.Therapeutic effect and recurrence rate of hysteroscopy guided selective endometrial resection of endometrial polyps[J].Chinese Journal of Family Planning & Gynecotokology,2017,(02):44.
[9]王利群,李萌,卢美松*.控制性超促排卵中新发子宫内膜息肉的研究进展[J].中国计划生育和妇产科,2017,(8):5.
[10]赵楠,张萍*.子宫内膜不典型增生患者保留生育功能的相关研究进展[J].中国计划生育和妇产科,2017,(9):15.
[11]从蓉俊*,孔彩霞,符圆圆,等.曼月乐和达芙通预防子宫内膜息肉切除术后复发的效果比较[J].中国计划生育和妇产科,2017,(3):39.
CONG Rong-jun*,KONG Cai-xia,FU Yuan- yuan,et al.Comparison of the effects of Mirena and Duphaston on prevention of recurrence after transcervical resection of polyp[J].Chinese Journal of Family Planning & Gynecotokology,2017,(02):39.
[12]周怀君.子宫内膜息肉的药物治疗新进展[J].中国计划生育和妇产科,2021,(7):33.[doi:10.3969/j.issn.1674-4020.2021.07.11]
[J].Chinese Journal of Family Planning & Gynecotokology,2021,(02):33.[doi:10.3969/j.issn.1674-4020.2021.07.11]